AXL and neuroblastoma: Our findings not only identify a molecular mechanism of resistance to ALK inhibition in ALKF1174L-driven NB, but also suggest that effective AXL or HSP90 inhibitors, combined with a TAE684-derived ALK inhibitor, could provide a useful strategy to overcome this complication.